X0203 0001354457 Nasdaq Stock Market LLC 0001708331 Virpax Pharmaceuticals, Inc. 001-40064

1055 Westlakes Drive, Suite 300 Berwyn PA PENNSYLVANIA 19312

(610) 727-4597 Common Stock 17 CFR 240.12d2-2(b) Aravind Menon Hearings Advisor 2025-07-21